Takuto Nakata

Takuto Nakata

Auto-generated profile, based on publicly available information

Takuto Nakata

Affiliations School of Medicine, Kanazawa University, Kanazawa, Japan, Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Kanazawa, Japan, Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
YTYudai Tanaka
Yudai Tanaka
TNTakuto Nakata
Takuto Nakata
KAKo Aiga
Ko Aiga
TETakahide Etani
Takahide Etani
RMRyota Muramatsu
Ryota Muramatsu
ANAkihiro Nomura
Akihiro Nomura
The remarkable performance of ChatGPT, launched in November 2022, has significantly impacted the field of natural language processing, inspiring the application of large language models as supportive tools in clinical practice and research worldwide. Although GPT-3.5 recently scored high on the United States Medical Licensing Examination, its performance on medical licensing examinations of other nations, especially non-English speaking nations, has not been sufficiently evaluated. This study assessed GPT’s performance on the National Medical Licensing Examination (NMLE) in Japan and compared it with the actual minimal passing rate for this exam. In particular, the performances of both the GPT-3.5 and GPT-4 models were considered for the comparative analysis. We initially used the GPT models and several prompts for 290 questions without image data from the 116th NMLE (held in February 2022 in Japan) to maximize the performance for delivering correct answers and explanations of the questions. Thereafter, we tested the performance of the best GPT model (GPT-4) with optimized prompts on a dataset of 262 questions without images from the latest 117th NMLE (held in February 2023). The best model with the optimized prompts scored 82.7% for the essential questions and 77.2% for the basic and clinical questions, both of which sufficed the minimum passing scoring rates of 80.0% and 74.6%, respectively. After an exploratory analysis of 56 incorrect answers from the model, we identified the three major factors contributing to the generation of the incorrect answers—insufficient medical knowledge, information on Japan-specific medical system and guidelines, and mathematical errors. In conclusion, GPT-4 with our optimized prompts achieved a minimum passing scoring rate in the latest 117th NMLE in Japan. Beyond its original design of answering examination questions for humans, these artificial intelligence (AI) models can serve as one of the best “sidekicks” for solving problems and addressing the unmet needs in the medical and healthcare fields.

24 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
YTYudai Tanaka
Yudai Tanaka
TNTakuto Nakata
Takuto Nakata
KAKo Aiga
Ko Aiga
TETakahide Etani
Takahide Etani
RMRyota Muramatsu
Ryota Muramatsu
ANAkihiro Nomura
Akihiro Nomura
The remarkable performance of ChatGPT, launched in November 2022, has significantly impacted the field of natural language processing, inspiring the application of large language models as supportive tools in clinical practice and research worldwide. Although ChatGPT recently scored high on the United States Medical Licensing Examination, its performance on medical licensing examinations of other nations, especially non-English speaking nations, has not been sufficiently evaluated. This study assessed ChatGPT’s performance on the National Medical Licensing Examination (NMLE) in Japan and compared it with the actual minimal passing rate for this exam. In particular, the performances of both the GPT-3.5 and GPT-4 models were considered for the comparative analysis. We initially used a model and prompt tuning set of 290 questions without image data from the previous 116 th NMLE (held in February 2022) to maximize the performance for delivering correct answers and explanations of the questions. Thereafter, we tested the performance of the best ChatGPT model (GPT-4) with tuned prompts on a dataset of 262 questions without images from the latest 117 th NMLE (held in February 2023). The best model with the tuned prompts scored 82.7% for the essential questions and 77.2% for the basic and clinical questions, both of which sufficed the minimum passing rates of 80.0% and 74.6%, respectively. Simultaneously, we identified the three major factors contributing to the generation of the incorrect answers—insufficient medical knowledge, information on Japan-specific medical system and guidelines, and mathematical errors. In conclusion, GPT-4 powered ChatGPT with our optimally tuned prompts achieved a minimum passing rate in the latest 117 th NMLE in Japan. Although we express strong concerns regarding the use of the current ChatGPT for medical purposes so far, these artificial intelligence models may soon have the potential to serve as one of the best “sidekicks” for solving medical and healthcare problems. Author summary: ChatGPT’s remarkable performance has inspired the use of large language models as supportive tools in clinical practice and research. Although it scored well in the US Medical Licensing Examination, its effectiveness in relevant examinations of non-English speaking countries remain unexplored. This study assessed the performance of ChatGPT with GPT-3.5 and GPT-4 models in Japan’s National Medical Licensing Examination (NMLE). Initially, we used a tuning set of 290 questions from the 116th NMLE, and then the GPT-4 model with tuned prompts was tested on 262 questions from the 117th NMLE. The model scored 82.7% for essential and 77.2% for basic and clinical questions, surpassing the minimum passing rates. Incorrect answers were attributed to insufficient medical knowledge, Japan-specific medical system information, and mathematical errors. In conclusion, GPT-4 powered ChatGPT achieved a minimum passing rate and might have the potential for a valuable tool for fulfilling the needs of medical and healthcare fields.

18 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
YTYudai Takana
Yudai Takana
TNTakuto Nakata
Takuto Nakata
HHHiroshi Hibino
Hiroshi Hibino
MNMasaaki Nishiyama
Masaaki Nishiyama
DIDaisuke Ino
Daisuke Ino
Facial expressions are widely recognized as universal indicators of underlying internal states in most species of animals, thereby presenting as a non-invasive measure for predicting physical and mental conditions. Despite the advancement of artificial intelligence-assisted tools for automated analysis of voluminous facial expression data in human subjects, the corresponding tools for mice still remain limited so far. Considering that mice are the most prevalent model animals for studying human health and diseases, a comprehensive characterization of emotion-dependent patterns of facial expressions in mice could extend our knowledge on the basis of emotions and the related disorders. Here, we present a framework for the development of a deep learning-powered tool for classifying mouse facial expressions. We demonstrate that our machine vision was capable of accurately classifying three different emotional states from mouse facial images. Moreover, we objectively determined how our classifier characterized the differences among the facial images through the use of an interpretation technique called Gradient-weighted Class Activation Mapping. Our approach is likely to facilitate the non-invasive decoding of a variety of emotions from facial images in mice.